Childrens Medical Center Corporation;Children's Medical Center Corporation
发明人:
Williams, David A.,De Vita, Serena
申请号：
AU2016252029
公开号：
AU2016252029A1
申请日:
2016.04.15
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
This disclosure relates to compositions including certain compounds identified by a quantitative, high throughput assay to be effective in the treatment of a Rac-GTPase mediated disorder (e.g., acute lymphoblastic or chronic myelogenous leukemia), as well as methods for the manufacture of and the use of these compounds for treating a Rac-GTPase mediated disorder.
